Latest
report on DNA sequencing is an excellent piece of material for the market
participants to understand the market dynamics. The report titled “Global DNA
Diagnostics Market (Product types, Application, Technology, End User and
Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights,
Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 –
2020,” offers an incisive and wider knowledge about the market.
Next-generation
Sequencing technologies are becoming a lethal growth weapon for the overall
market.
lps to decode numerous deadly diseases including cancer. Further,
it increases the throughput and reduces the sequencing cost. Enabling re-sequencing of human genomes, it helps in identifying the
regulatory elements in the pathological process and genes. It is increasingly becoming popular in DNA diagnostics.
Analyst
said that the technology is best and economical to find the genetic cause of a
disease.
“RNA
sequence might replace microarray analysis in gene expression studies in the
foreseeable future. Next generation sequencing is a quick and affordable way to
determine the genetic causes of diseases. The targeted sequence enables the
identification of disease-causing agents for the diagnosis of pathological
conditions,” AMR analyst.
Analyst
further added “Next generation technology is bridging the gap between
traditional and personalized medication. Companies offering next generation
sequencing are now focusing on cancer management, rare disease treatment and
development of genetic therapies. “
It
is a technology that would take DNA sequencing to next level.
